Your browser doesn't support javascript.
loading
Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer.
Chen, Sisi; Li, Ying; Wu, Muyao; Xue, Lian; Zhu, Jianyu; Wu, Mi; Zhang, Qiuting; He, Guangchun; Li, Guifei; Fu, Shujun; Zheng, Chanjuan; Deng, Xiyun.
Afiliação
  • Chen S; Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Departments of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, China.
  • Li Y; Key Laboratory of Translational Cancer Stem Cell Research, Hunan Normal University, Changsha, China.
  • Wu M; Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Departments of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, China.
  • Xue L; Key Laboratory of Translational Cancer Stem Cell Research, Hunan Normal University, Changsha, China.
  • Zhu J; Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Departments of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, China.
  • Wu M; Key Laboratory of Translational Cancer Stem Cell Research, Hunan Normal University, Changsha, China.
  • Zhang Q; Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Departments of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, China.
  • He G; Key Laboratory of Translational Cancer Stem Cell Research, Hunan Normal University, Changsha, China.
  • Li G; Key Laboratory of Translational Cancer Stem Cell Research, Hunan Normal University, Changsha, China.
  • Fu S; Department of Pathophysiology, Jishou University School of Medicine, Jishou, China.
  • Zheng C; Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Departments of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, China.
  • Deng X; Key Laboratory of Translational Cancer Stem Cell Research, Hunan Normal University, Changsha, China.
Front Oncol ; 12: 731528, 2022.
Article em En | MEDLINE | ID: mdl-35174077

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça